Boston Scientific Corporation
NYSE:BSX · New York Stock Exchange
+$0.45 today
Vol 30.83M · Avg 19.45M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-55.75%
Period High
$108.14
Period Low
$44.95
Latest
$45.29
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector

Amgen Inc.
NASDAQ:AMGN
$181.01B

Abbott Laboratories
NYSE:ABT
$153.82B

Gilead Sciences, Inc.
NASDAQ:GILD
$152.65B

Pfizer Inc.
NYSE:PFE
$144.22B

Danaher Corporation
NYSE:DHR
$126.07B

Stryker Corporation
NYSE:SYK
$119.35B

Medtronic plc
NYSE:MDT
$101.66B

Sanofi
NASDAQ:SNY
$101.44B

McKesson Corporation
NYSE:MCK
$87.60B

HCA Healthcare, Inc.
NYSE:HCA
$83.16B
What is the latest BSX filing?
The latest filing shown is 4 dated Jun 1, 2026.
How many recent filings does BSX have?
Intrinsic Alpha currently shows 20 recent filings for BSX.
Explore More
Continue the stock analysis
Jump to another research area for this company.